GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
1.870
-0.120 (-6.03%)
At close: Feb 27, 2026, 4:00 PM EST
1.880
+0.010 (0.53%)
After-hours: Feb 27, 2026, 4:16 PM EST
GoodRx Holdings Stock Forecast
Stock Price Forecast
The 9 analysts that cover GoodRx Holdings stock have a consensus rating of "Buy" and an average price target of $4.64, which forecasts a 148.13% increase in the stock price over the next year. The lowest target is $2.75 and the highest is $7.00.
Price Target: $4.64 (+148.13%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GoodRx Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 3 | 2 | 1 |
| Hold | 4 | 4 | 5 | 5 | 6 | 7 |
| Sell | 0 | 0 | 0 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 11 | 11 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +60.43% | Feb 27, 2026 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 27, 2026 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $5.25 → $2.75 | Strong Buy → Hold | Downgrades | $5.25 → $2.75 | +47.06% | Jan 22, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $5 → $4.5 | Strong Buy | Maintains | $5 → $4.5 | +140.64% | Jan 9, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +113.90% | Dec 18, 2025 |
Financial Forecast
Revenue This Year
831.44M
from 796.85M
Increased by 4.34%
Revenue Next Year
890.07M
from 831.44M
Increased by 7.05%
EPS This Year
0.44
from 0.09
Increased by 416.33%
EPS Next Year
0.52
from 0.44
Increased by 17.54%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 888.9M | 971.8M | |||
| Avg | 831.4M | 890.1M | |||
| Low | 773.6M | 826.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.6% | 16.9% | |||
| Avg | 4.3% | 7.1% | |||
| Low | -2.9% | -0.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 0.53 | 0.61 | ||
| Avg | 0.44 | 0.52 | ||
| Low | 0.37 | 0.40 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 514.6% | 38.1% | ||
| Avg | 416.3% | 17.5% | ||
| Low | 335.9% | -8.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.